Evidence map›Paper›PMID 24154686›Full record

ArticleMetabolic brain disease2014

Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats.

Gerald A Dienel, Nancy F Cruz

Open access · greenAbstract read
In one paragraph

Article in Metabolic brain disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gerald A DienelDepartment of Neurology, University of Arkansas for Medical Sciences, Slot 500, 4301 W. Markham St., Shorey Bldg., Room 715, Little Rock, AR, 72205, USA, gadienel@uams.edu.
Nancy F Cruz
University of Arkansas for Medical Sciences · US

Funding

Endoplasmic reticulum stress in diabetic brainR01DK081936 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI DIENEL, GERALD A. · 2009 to 2012
$1.3M
PATHOGENESIS OF HEPATIC COMAR01DK016739 · NIDDK · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI COOPER, ARTHUR JOSEPH · 1986 to 1994
–
NIDDK NIH HHS DK081936NIDDK NIH HHS DK16739NIDDK NIH HHS R01 DK016739NIDDK NIH HHS R01 DK081936
6 · The paper itself

Abstract

Portacaval shunting is a model for hepatic encephalopathy that causes chronic hyperammonemia, disruption of metabolic, signaling, and neurotransmitter systems, and progressive morphological changes. Exposure of cultured cells to ammonia raises intralysosomal pH and inhibits proteolysis, and the present study tested the hypothesis that proteolytic capacity is diminished in portacaval-shunted rats. Proteins were labeled in vivo with tracer doses of diisopropylfluorophosphate (DFP) and clearance of label was assayed. This approach labeled proteins independent of protein synthesis, which is reported to be altered in shunted rats, and avoided complications arising from re-utilization of labeled amino acids that causes underestimation of degradation rate. Characterization of DFP labeling showed that protein labeling was fast, about 50% of the label was released during a 24 h interval, labeling by DFP metabolites was negligible, inhibition of brain acetylcholinesterase was not detectable, and labeling by [(3)H]- and [(14)C]DFP was equivalent. To assay degradative capacity, proteins were first labeled with [(3)H]DFP, followed by labeling with [(14)C]DFP that was given 24 or 72 h later. The (3)H/(14)C ratio in each animal was used as a relative measure of removal of (3)H-labeled proteins. (3)H/(14)C ratios were generally significantly higher in portacaval-shunted rats than in controls, consistent with reduced proteolytic capacity. Assays of amino acid incorporation into brain protein generally replicated literature reports, supporting the conclusion that protein synthesis unlikely to be markedly inhibited and amino acid recycling influences calculated protein synthesis rates in shunted rats. Therapeutic strategies to reduce ammonia level would help normalize lysosomal functions and protein and lipid turnover.

Indexed as

ProteolysisAmino AcidsAnimalsFluorescent DyesHepatic EncephalopathyHydrogen-Ion ConcentrationHyperammonemiaIsoflurophateLysosomesMalePortacaval Shunt, SurgicalProteinsRatsRats, WistarAmino AcidsFluorescent DyesIsoflurophateProteins

Identifiers

PMID24154686
PMCPMC4000281
OpenAlexW2094552991

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.